Companies · Other Health Care
CHICAGO · Other Health Care
Diligence memoA one-page analyst read on TVG-SHC Holdings, LLC — recommendation, valuation, rhythm, risks.→TVG-SHC Holdings, LLC looks fair against its niche peers and is dormant on financing cadence.
Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.
Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.
Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.
TVG-SHC Holdings, LLC behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.
No named principal in this company's public records yet — see all operators below.
Explore how these operators interlock with other companies in the operator network.
TVG-SHC Holdings, LLC is one of 5377 Other Health Care companies tracked from CHICAGO. By capital raised it ranks among the largest (ahead of 94% of sector peers), and among the largest by modeled valuation est..
Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.
As reported in public records reported — not modeled.
Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.
The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.
Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed, Series A, Series B — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 20%.
Round size and date are reported; the stage label is inferred from round size (latest is Series C — a $40M–$100M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.
Not enough modeled valuation points to chart a trajectory.
Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.
Raised more than 94% of sector peers (real $). Modeled value above 98% of peers (estimate).
A tighter cohort than the sector chart above — only companies at the same stage (Series C) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #5 of 33.
| Company | Stage | Raised · real | Value · est | vs peer med. |
|---|---|---|---|---|
| ACON IWP Holdings, L.L.C. | Series C | $91.8M | $2.1B | 1.84× |
| Erc Group Holdings, Llc | Series C | $91.7M | $2.1B | 1.83× |
| Cpf Senior Living Holdings, Llc | Series C | $158.4M | $2.0B | 1.72× |
| Corvus Pharmaceuticals, Inc. | Series C | $87.7M | $1.7B | 1.50× |
| TVG-SHC Holdings, LLC this company | Series C | $70.4M | $1.6B | 1.41× |
| Sequel Youth & Family Services, LLC | Series C | $97.8M | $1.5B | 1.32× |
| Wave Life Sciences Pte Ltd | Series C | $77.8M | $1.5B | 1.32× |
| MedSynergies, Inc. | Series C | $118.0M | $1.5B | 1.30× |
| HALT Medical, Inc | Series C | $177.7M | $1.4B | 1.27× |
| Med Fusion, LLC | Series C | $92.9M | $1.4B | 1.22× |
| Data Driven Delivery Systems, LLC | Series C | $67.0M | $1.4B | 1.22× |
| Remedy Partners, Inc. | Series C | $110.0M | $1.4B | 1.20× |
Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.
| Stage | Amount · real | Announced | Post-money · est | Value · est | Conf. |
|---|---|---|---|---|---|
| Series C | $70.4M | 2015-12-21 | $469.3M | $1.6B | 90% |
Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.
Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.
Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.
| Person | Role | Also runs | Tied since |
|---|---|---|---|
| Harreld N. Kirkpatrick III | — | 2 other | 2015-12 |
| Amy N. Christensen | — | 1 other | 2015-12 |
| Janet Elkin | — | 1 other | 2015-12 |
TVG-SHC Holdings, LLC is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.
Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.
| Company | Sector | Stage | Raised · real | Value · est | Why similar |
|---|---|---|---|---|---|
| Vistria SHC Holdings, LLC | Other Health Care | Series B | $39.7M | $879.5M | network2 shared operators · same sector |
| Bind Benefits, Inc. | Other Health Care | Series C | $70.0M | $1.6B | same sector · same stage |
| Omada Health, Inc. | Other Health Care | Series C | $71.5M | $1.1B | same sector · same stage |
| 4Paws Dx, Inc. | Other Health Care | Series C | $69.1M | $780.4M | same sector · same stage |
| Nucleus Radiopharma, Inc. | Other Health Care | Series C | $72.1M | $662.9M | same sector · same stage |
| Mydna, Inc | Other Health Care | Series C | $72.1M | $1.4B | same sector · same stage |
| Revolution Global, LLC | Other Health Care | Series C | $72.6M | $1.1B | same sector · same stage |
| Dror Ortho-Design, Inc. | Other Health Care | Series C | $72.9M | $638.1M | same sector · same stage |
See where TVG-SHC Holdings, LLC sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.
If you work at TVG-SHC Holdings, LLC, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.
Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.